Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancer

Francesco Schettini, S. Nucera, F Brasó-Maristany, Irene De Santo, T. Pascual, M Bergamino, P. Galván, B. Conte, E Seguí, I. García Fructuoso,

ESMO Open · 2024 · 16 citations · 24 references

DOIFull text

Open access

References

24